IMTX
immatics biotechnologies GmbH
IMTXW5
$2.40arrow_drop_up3.44%$0.08
Penny Stock
IMTX
IMTXW5
$2.40
arrow_drop_up3.44%Performance History
| Key Stats | |
|---|---|
| Open | $2.40 |
| Prev. Close | $2.32 |
| EPS | - |
| Dividend | Non-Dividend |
| Next Earnings Date | - |
| Dividend Yield % | - |
| Market Cap | - |
| PE Ratio | - |
| LOW | HIGH | |
|---|---|---|
| Day Range | 2.40 | 2.40 |
| 52 Week Range | 1.79 | 4.14 |
| Ratios | |
|---|---|
| Revenue | - |
| EPS | - |
Score Breakdown
Welcome to Stocklytics
Don't miss out on the opportunity to stay ahead in the ever-changing world of finance.
Analyst Forecast
Period: Next 12 Months
•Analyst Ratings
••
About immatics biotechnologies GmbH (IMTXW)
- Sector
- Industry
- CEO
- Headquarters
- Employees
- 0
- Exchange
- NASDAQ
Keep an eye on immatics biotechnologies GmbH
Adding the right stocks to your watchlist can provide valuable insights and opportunities for strategic decision-making.
Frequently Asked Questions
help
What is immatics biotechnologies GmbH's (IMTXW) price per share?
The current price per share for immatics biotechnologies GmbH (IMTXW) is $2.4. The stock has seen a price change of $0.08 recently, indicating a 3.45% change. This reflects the stock's recent market performance and investor sentiment.
help
What is the 52-week high and low for immatics biotechnologies GmbH (IMTXW)?
For immatics biotechnologies GmbH (IMTXW), the 52-week high is $4.14, which is 72.5% from the current price. The 52-week low is $1.79, the current price is 34.08% above the 52-week low. This gives investors an insight into the stock's volatility and price range over the past year.
help
Is immatics biotechnologies GmbH (IMTXW) a growth stock?
immatics biotechnologies GmbH (IMTXW) has shown an average price growth of 0.41% over the past three years. It has received a score of 0 out of 100 based on the Stocklytics formula. The interpretation of this score in terms of classifying immatics biotechnologies GmbH as a growth stock may vary, considering it is one of many factors investors might evaluate, including market trends, financial performance, and future prospects of the company.
help
What is immatics biotechnologies GmbH (IMTXW) stock price performance year to date (YTD)?
As of the latest data, immatics biotechnologies GmbH (IMTXW) has a year-to-date price change of -10.78%. Over the past month, the stock has experienced a price change of -4%. Over the last three months, the change has been -37.5%. Over the past six months, the figure is -35.14%.
help
Is immatics biotechnologies GmbH (IMTXW) a profitable company?
immatics biotechnologies GmbH (IMTXW) has a net income of -$96.99M, which represents the company's total earnings after all expenses have been deducted from revenues. The gross margin of indicates the percentage of revenue that exceeds the cost of goods sold, and the operating margin of -141.64% reflects the percentage of revenue remaining after covering variable production costs, highlighting the efficiency of the company's core operations. Total revenue stands at , although specific revenue growth data is currently not available. Operating income is noted at -$101.72M. Furthermore, the EBITDA is -$105.53M.
help
What is the market capitalization of immatics biotechnologies GmbH (IMTXW)?
immatics biotechnologies GmbH (IMTXW) has a market capitalization of . The average daily trading volume is 434, indicating the stock's liquidity and investor engagement.
News
IMMATICS
ACTENGINE® IMA203
PRAME
METASTATIC MELANOMA
TCR BISPECIFICS
IMA401
IMA402
ALISE REICIN
8/13/2024Immatics Announces Second Quarter 2024 Financial Results and Business Update
MEMO THERAPEUTICS AG
PAUL CARTER
ANTIBKV
VIROLOGY
BIOPHARMA
7/8/2024Memo Therapeutics AG appoints Paul Carter as Chairperson - GlobeNewswire